col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


39 Ergebisse       Seite 1

 [1] 
The Rockefeller University Press: The Journal of Experimental Medicine
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2023―Jun―16 Mammalian infections with highly pathogenic avian influenza viruses renew concerns of pandemic potential Brad Gilbertson, Kanta Subbarao
2 [GO] 2023―Mai―03 SARS-CoV-2 infection and recovery in children: Distinct T cell responses in MIS-C compared to COVID-19 Ksenia Rybkina, Joseph N. Bell, Marissa C. Bradley, Teddy Wohlbold, Marika Scafuro, Wenzhao Meng, et al. (+11)
3 [GO] 2023―Mrz―07 Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia Ana García-García, Rebeca Pérez de Diego, Carlos Flores, Darawan Rinchai, Jordi Solé-Violán, Àngela Deyà-Martínez, et al. (+157)
4 [GO] 2022―Dez―13 Antibody feedback contributes to facilitating the development of Omicron-reactive memory B cells in SARS-CoV-2 mRNA vaccinees Takeshi Inoue, Ryo Shinnakasu, Chie Kawai, Hiromi Yamamoto, Shuhei Sakakibara, Chikako Ono, et al. (+14)
5 [GO] 2022―Nov―07 Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination Aurélien Sokal, Paul Bastard, Pascal Chappert, Giovanna Barba-Spaeth, Slim Fourati, Alexis Vanderberghe, et al. (+46)
6 [GO] 2022―Nov―03 SARS-CoV-2 Spike protein suppresses CTL-mediated killing by inhibiting immune synapse assembly Anna Onnis, Emanuele Andreano, Chiara Cassioli, Francesca Finetti, Chiara Della Bella, Oskar Staufer, et al. (+6)
7 [GO] 2022―Aug―29 Correction: IgM antibodies derived from memory B cells are potent cross-variant neutralizers of SARS-CoV-2 Malika Hale, Jason Netland, Yu Chen, Christopher D. Thouvenel, Katherine Nabel Smith, Lucille M. Rich, et al. (+14)
8 [GO] 2022―Jul―07 Plasma and memory antibody responses to Gamma SARS-CoV-2 provide limited cross-protection to other variants Marianna Agudelo, Frauke Muecksch, Dennis Schaefer-Babajew, Alice Cho, Justin DaSilva, Eva Bednarski, et al. (+20)
9 [GO] 2022―Jul―01 Antibody evolution to SARS-CoV-2 after single-dose Ad26.COV2.S vaccine in humans Alice Cho, Frauke Muecksch, Zijun Wang, Tarek Ben Tanfous, Justin DaSilva, Raphael Raspe, et al. (+18)
10 [GO] 2022―Jun―16 Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia Qian Zhang, Daniela Matuozzo, Jérémie Le Pen, Danyel Lee, Leen Moens, Takaki Asano, et al. (+167)
11 [GO] 2022―Jun―15 Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2 Cyril Planchais, Ignacio Fernández, Timothée Bruel, Guilherme Dias de Melo, Matthieu Prot, Maxime Beretta, et al. (+126)
12 [GO] 2022―Apr―14 SARS-CoV-2 infection relaxes peripheral B cell tolerance Moriah J. Castleman, Megan M. Stumpf, Nicholas R. Therrien, Mia J. Smith, Kelsey E. Lesteberg, Brent E. Palmer, et al. (+6)
13 [GO] 2021―Okt―20 Correction: Mapping and role of T cell response in SARS-CoV-2-infected mice Zhen Zhuang, Xiaomin Lai, Jing Sun, Zhao Chen, Zhaoyong Zhang, Jun Dai, et al. (+22)
14 [GO] 2021―Okt―18 Identification of conserved SARS-CoV-2 spike epitopes that expand public cTfh clonotypes in mild COVID-19 patients Xiuyuan Lu, Yuki Hosono, Masamichi Nagae, Shigenari Ishizuka, Eri Ishikawa, Daisuke Motooka, et al. (+24)
15 [GO] 2021―Okt―10 Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related viruses Ryo Shinnakasu, Shuhei Sakakibara, Hiromi Yamamoto, Po-hung Wang, Saya Moriyama, Nicolas Sax, et al. (+13)
16 [GO] 2021―Aug―23 The early interferon catches the SARS-CoV-2 Thomas Decker
17 [GO] 2021―Aug―20 Correction: Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs Jonathan Lopez, Marine Mommert, William Mouton, Andrés Pizzorno, Karen Brengel-Pesce, Mehdi Mezidi, et al. (+17)
18 [GO] 2021―Aug―06 Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs Jonathan Lopez, Marine Mommert, William Mouton, Andrés Pizzorno, Karen Brengel-Pesce, Mehdi Mezidi, et al. (+17)
19 [GO] 2021―Jan―19 Mapping and role of T cell response in SARS-CoV-2-infected mice Zhen Zhuang, Xiaomin Lai, Jing Sun, Zhao Chen, Zhaoyong Zhang, Jun Dai, et al. (+22)
20 [GO] 2021―Jan―14 Neuroinvasion of SARS-CoV-2 in human and mouse brain Eric Song, Ce Zhang, Benjamin Israelow, Alice Lu-Culligan, Alba Vieites Prado, Sophie Skriabine, et al. (+33)
21 [GO] 2020―Dez―09 COVID-19 stokes inflammasomes Clare Bryant
22 [GO] 2020―Dez―02 Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients Tamara S. Rodrigues, Keyla S.G. de Sá, Adriene Y. Ishimoto, Amanda Becerra, Samuel Oliveira, Leticia Almeida, et al. (+38)
23 [GO] 2020―Nov―23 Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo Alexandra Schäfer, Frauke Muecksch, Julio C.C. Lorenzi, Sarah R. Leist, Melissa Cipolla, Stylianos Bournazos, et al. (+12)
24 [GO] 2020―Okt―16 SARS-CoV-2 vaccine development, access, and equity Jerome H. Kim
25 [GO] 2020―Okt―13 An unconventional view of COVID-19 T cell immunity Hui-Fern Koay, Thomas S. Fulford, Dale I. Godfrey
26 [GO] 2020―Sep―29 An ace model for SARS-CoV-2 infection Jack Major, Andreas Wack
27 [GO] 2020―Sep―14 Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19 Coraline Radermecker, Nancy Detrembleur, Julien Guiot, Etienne Cavalier, Monique Henket, Céline d’Emal, et al. (+5)
28 [GO] 2020―Sep―14 SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology Flavio Protasio Veras, Marjorie Cornejo Pontelli, Camila Meirelles Silva, Juliana E. Toller-Kawahisa, Mikhael de Lima, Daniele Carvalho Nascimento, et al. (+40)
29 [GO] 2020―Sep―10 Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies Ting Zhou, Tina Tianjiao Su, Tenny Mudianto, Jun Wang
30 [GO] 2020―Sep―04 Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients Youenn Jouan, Antoine Guillon, Loïc Gonzalez, Yonatan Perez, Chloé Boisseau, Stephan Ehrmann, et al. (+8)
31 [GO] 2020―Aug―04 Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling Benjamin Israelow, Eric Song, Tianyang Mao, Peiwen Lu, Amit Meir, Feimei Liu, et al. (+7)
32 [GO] 2020―Jul―31 Lessons of COVID-19: A roadmap for post-pandemic science Tanya S. Freedman, Mark B. Headley, Nina Serwas, Megan Ruhland, Carlos A. Castellanos, Alexis J. Combes, Matthew F. Krummel
33 [GO] 2020―Jul―31 Lessons of COVID-19: Virtual conferences Stephanie Houston
34 [GO] 2020―Jul―21 Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses Fabian Schmidt, Yiska Weisblum, Frauke Muecksch, Hans-Heinrich Hoffmann, Eleftherios Michailidis, Julio C.C. Lorenzi, et al. (+15)
35 [GO] 2020―Jul―17 Blocking inflammation on the way: Rationale for CXCR2 antagonists for the treatment of COVID-19 Lars M. Koenig, Daniel F.R. Boehmer, Philipp Metzger, Max Schnurr, Stefan Endres, Simon Rothenfusser
36 [GO] 2020―Jul―17 Neutrophils and COVID-19: Nots, NETs, and knots Carl Nathan
37 [GO] 2020―Jun―18 The renin-angiotensin system: An integrated view of lung disease and coagulopathy in COVID-19 and therapeutic implications Betty Diamond
38 [GO] 2020―Apr―16 Targeting potential drivers of COVID-19: Neutrophil extracellular traps Betsy J. Barnes, Jose M. Adrover, Amelia Baxter-Stoltzfus, Alain Borczuk, Jonathan Cools-Lartigue, James M. Crawford, et al. (+17)
39 [GO] 2020―Apr―14 COVID-19 and emerging viral infections: The case for interferon lambda Ludmila Prokunina-Olsson, Noémie Alphonse, Ruth E. Dickenson, Joan E. Durbin, Jeffrey S. Glenn, Rune Hartmann, et al. (+10)
 [1] 

39 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec